{
    "_id":"6984d02d155c6769eb881421",
    "diagnostic_test":"microsatellite_instability",
    "annotations":[
        {
        "microsatellite_instability":[
            {
                "data_source":"curated_by_worthey",
                "version":"curated_01-26-2026",
                "value":{
                    "microsatellite-instability-high":{
                    "definition":"Multiple microsatellite loci show instability",
                    "implication":"Indicates defective mismatch repair (MMR) system.",
                    "clinical_relevance":[
                        "Suggests potential Mismatch Repair associated disease. Eg. Lynch Syndrome (especially in colorectal, endometrial, and other cancers).",
                        "May predict better response to immunotherapy (e.g., checkpoint inhibitors like pembrolizumab).",
                        "May influence treatment choices and prognosis."
                    ],
                    "report_language":[
                        "MSI-High",
                        "MSI-H",
                        "High-level MSI",
                        "High",
                        "High-MSI",
                        "Microsatellite instability detected",
                        "Mismatch repair deficient (dMMR)",
                        "MSI positive",
                        "MSI-positive"
                    ],
                    "underlying_results":{
                        "pcr-based-test":"MSI-High: Instability in >= 2 of 5 markers",
                        "ngs-based-test":"MSI score is often reported as a percentage or score (e.g., from 0 to 1 or 0 to 100%). >= 0.20 (or >= 20%) is considered MSI-High"
                    }
                    },
                    "microsatellite-instability-low":{
                    "definition":"Only 1 of several tested microsatellite loci is unstable.",
                    "implication":"Generally considered not clinically significant on its own.",
                    "clinical_relevance":[
                        "Usually treated as microsatellite stable (MSS).",
                        "Rarely linked to mismatch repair defects.",
                        "May be considered borderline in some contexts, but often doesn’t affect treatment."
                    ],
                    "report_language":[
                        "MSI-Low",
                        "MSI-L",
                        "Low-level MSI",
                        "Low",
                        "Microsatellite instability - low",
                        "Indeterminate MSI - sometimes used if data is borderline or not clearly MSI-H or MSS"
                    ],
                    "underlying_result":{
                        "pcr-based-tests":"MSI-Low: Instability in 1 of 5 markers",
                        "ngs-based-test":"MSI score is often reported as a percentage or score (e.g., from 0 to 1 or 0 to 100%). 0.10-0.19 (or ~10-19%) - MSI-Low"
                    }
                    },
                    "microsatellite-instability-stable":{
                    "definition":"No instability detected at tested loci.",
                    "implication":"Normal DNA mismatch repair function.",
                    "clinical_relevance":[
                        "Does not support Lynch syndrome.",
                        "Less likely to benefit from immunotherapy.",
                        "Suggests that other pathways (e.g., chromosomal instability) may be driving tumorigenesis."
                    ],
                    "report_language":[
                        "Microsatellite stable",
                        "MSS",
                        "No microsatellite instability detected",
                        "Mismatch repair proficient (pMMR)",
                        "MSI negative"
                    ],
                    "underlying_result":{
                        "pcr-based-tests":"MSS: No unstable markers",
                        "ngs-based-test":"MSI score is often reported as a percentage or score (e.g., from 0 to 1 or 0 to 100%). <0.10 (or <10%) - Microsatellite Stable"
                    }
                    },
                    "microsatellite-instability-indeterminate":{
                    "definition":"Status cannot be confidently classified as MSI-High, MSI-Low, or MSS due to borderline, inconclusive, or technically insufficient results.",
                    "implication":"Further testing or repeat analysis required; this category does not provide actionable diagnostic or treatment guidance on its own.",
                    "clinical_relevance":[
                        "May arise from poor sample quality, low tumor content, or ambiguous molecular results.",
                        "Should prompt re-evaluation using alternate methods (e.g., IHC for MMR proteins, repeat MSI testing, or alternative NGS panels).",
                        "In some cases, clinical judgment may guide treatment decisions pending further clarification."
                    ],
                    "report_language":[
                        "MSI-indeterminate",
                        "Borderline MSI",
                        "Equivocal MSI result",
                        "Uninterpretable MSI",
                        "Ambiguous MSI"
                    ],
                    "underlying_result":{
                        "pcr-based-tests":"Inconclusive due to poor amplification or insufficient loci evaluated. Results that do not meet clear thresholds for MSI-H, MSI-L, or MSS.",
                        "ngs-based-test":"MSI score is often reported as a percentage or score (e.g., from 0 to 1 or 0 to 100%). MSI score in the range of 0.10–0.19 (10–19%) when not clearly meeting MSI-Low criteria. Low confidence or quality flags from variant calling pipeline or insufficient coverage."
                    }
                    }
                }
            }
        ]
        }
    ]
}
